D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Broadcom
AVGO
|
+$520M |
| 2 |
Accenture
ACN
|
+$474M |
| 3 |
Intel
INTC
|
+$436M |
| 4 |
Adobe
ADBE
|
+$318M |
| 5 |
Northrop Grumman
NOC
|
+$262M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.23B |
| 2 |
Apple
AAPL
|
+$900M |
| 3 |
Microsoft
MSFT
|
+$733M |
| 4 |
Netflix
NFLX
|
+$637M |
| 5 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$542M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 17.68% |
| 2 | Consumer Discretionary | 10.14% |
| 3 | Financials | 7.13% |
| 4 | Healthcare | 6.41% |
| 5 | Industrials | 4.57% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DCH
2951
Dauch Corp
DCH
$1.34B
| $1.18M | ﹤0.01% |
169,405
+139,314
| +463% | +$1.03M |
|
|
KALV
2952
DELISTED
KalVista Pharmaceuticals
KALV
| $1.18M | ﹤0.01% |
100,061
+12,968
| +15% | +$151K |
|
2953
Intapp
INTA
$2.52B
| $1.18M | ﹤0.01% |
32,059
-119,702
| -79% | -$4.07M |
|
2954
KT
KT
$8.62B
| $1.18M | ﹤0.01% |
85,997
+54,301
| +171% | +$716K |
|
2955
MYR Group
MYRG
$5.19B
| $1.17M | ﹤0.01% |
8,658
-1,900
| -18% | -$297K |
|
2956
CEMIG Preferred Shares
CIG
$6.26B
| $1.17M | ﹤0.01% |
666,675
+63,319
| +10% | +$121K |
|
2957
Bruker
BRKR
$9.57B
| $1.17M | ﹤0.01% |
18,372
-60,155
| -77% | -$4.53M |
|
2958
CALL
Academy Sports + Outdoors
ASO
$2.94B
| $1.17M | ﹤0.01% |
+21,900
| New | +$1.24M |
|
2959
Xeris Biopharma Holdings
XERS
$1.39B
| $1.17M | ﹤0.01% |
518,024
-188,987
| -27% | -$381K |
|
2960
Dimensional US Large Cap Value ETF
DFLV
$6.84B
| $1.17M | ﹤0.01% |
+40,307
| New | +$1.17M |
|
2961
MasterCraft Boat Holdings
MCFT
$579M
| $1.16M | ﹤0.01% |
61,639
+16,201
| +36% | +$337K |
|
2962
Steris
STE
$22.3B
| $1.16M | ﹤0.01% |
+5,298
| New | +$1.15M |
|
2963
CALL
DHT Holdings
DHT
$2.99B
| $1.16M | ﹤0.01% |
+100,000
| New | +$1.17M |
|
|
BNT
2964
Brookfield Wealth Solutions
BNT
$11.8B
| $1.16M | ﹤0.01% |
41,648
+7,950
| +24% | +$221K |
|
2965
PUT
Boston Scientific
BSX
$69.5B
| $1.16M | ﹤0.01% |
+15,000
| New | +$1.1M |
|
2966
Essent Group
ESNT
$6.08B
| $1.15M | ﹤0.01% |
+20,518
| New | +$1.14M |
|
|
GOOS
2967
CALL
Canada Goose Holdings
GOOS
$872M
| $1.15M | ﹤0.01% |
89,000
+2,100
| +2% | +$26.1K |
|
2968
PUT
Rapid7
RPD
$645M
| $1.15M | ﹤0.01% |
+26,600
| New | +$1.11M |
|
2969
CALL
Regal Rexnord
RRX
$13.7B
| $1.15M | ﹤0.01% |
8,500
| – | – |
|
|
HCP
2970
PUT
DELISTED
HashiCorp, Inc. Class A Common Stock
HCP
| $1.15M | ﹤0.01% |
34,100
+2,100
| +7% | +$65.3K |
|
2971
Saic
SAIC
$4.95B
| $1.15M | ﹤0.01% |
9,742
+7,178
| +280% | +$909K |
|
2972
PUT
NovoCure
NVCR
$1.73B
| $1.14M | ﹤0.01% |
66,700
+25,400
| +62% | +$447K |
|
|
BPMC
2973
PUT
DELISTED
Blueprint Medicines
BPMC
| $1.14M | ﹤0.01% |
10,600
+3,300
| +45% | +$330K |
|
2974
iShares MSCI Canada ETF
EWC
$6.13B
| $1.14M | ﹤0.01% |
30,788
+20,764
| +207% | +$781K |
|
2975
Revolution Medicines
RVMD
$39.9B
| $1.14M | ﹤0.01% |
29,294
-44,363
| -60% | -$1.66M |
|
Similar funds
D.E. Shaw & Co's Q2 2024 Portfolio in Review
As of Q2 2024, D.E. Shaw & Co held 4,975 positions worth $107B, down 8.5% from $117B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
D.E. Shaw & Co withdrew a net $20B in Q2 2024, closing 541 positions and reducing 1,567 holdings. Its most notable exit was Pioneer Natural Resource Co., an estimated $542M position sold in full.
By sector, the portfolio is most concentrated in Technology at 18% of assets, down from 18% a quarter earlier, followed by Consumer Discretionary and Financials.
Against the trend, D.E. Shaw & Co opened a new position in iShares JPMorgan USD Emerging Markets Bond ETF worth $258M.
- D.E. Shaw & Co's largest Q2 2024 buy was iShares JPMorgan USD Emerging Markets Bond ETF: 2,917,600 shares worth $258M.
- D.E. Shaw & Co added most to Broadcom in Q2 2024, an estimated $520M increase.
- D.E. Shaw & Co's biggest Q2 2024 reduction was NVIDIA, cutting an estimated $1.23B.
- D.E. Shaw & Co fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $542M.
- D.E. Shaw & Co's ten largest holdings make up 11% of its $107B portfolio in Q2 2024.
- D.E. Shaw & Co opened 693 new positions and closed 541 in Q2 2024.
- D.E. Shaw & Co's portfolio value fell 8.5% quarter-over-quarter to $107B.
Based on D.E. Shaw & Co's 13F filing for Q2 2024, filed 14 Aug 2024.